Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.

Rodgers JJ, McClure R, Epis MR, Cohen RJ, Leedman PJ, Harvey JM; Australian Prostate Cancer BioResource, Thomas MA, Bentel JM.

J Cell Biochem. 2019 Jan;120(1):848-860. doi: 10.1002/jcb.27446. Epub 2018 Aug 30.

PMID:
30161276
2.

The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.

Halliday GC, Junckerstorff RC, Bentel JM, Miles A, Jones DTW, Hovestadt V, Capper D, Endersby R, Cole CH, van Hagen T, Gottardo NG.

J Clin Neurosci. 2018 Jan;47:163-167. doi: 10.1016/j.jocn.2017.09.013. Epub 2017 Oct 6.

3.

Erdheim-Chester disease associated with a novel, complex BRAF p.Thr599_Val600delinsArgGlu mutation.

Bentel JM, Thomas MA, Rodgers JJ, Arooj M, Gray E, Allcock R, Fermoyle S, Mancera RL, Cannell P, Parry J.

BMJ Case Rep. 2017 Apr 28;2017. pii: bcr-2017-219720. doi: 10.1136/bcr-2017-219720.

4.

Activity of ABCG2 Is Regulated by Its Expression and Localization in DHT and Cyclopamine-Treated Breast Cancer Cells.

Chua VY, Larma I, Harvey J, Thomas MA, Bentel JM.

J Cell Biochem. 2016 Oct;117(10):2249-59. doi: 10.1002/jcb.25523. Epub 2016 Apr 7.

PMID:
26917208
5.

Are all RAS mutations the same? Coexisting KRAS and NRAS mutations in a caecal adenocarcinoma and contiguous tubulovillous adenoma.

Vagaja NN, Parry J, McCallum D, Thomas MA, Bentel JM.

J Clin Pathol. 2015 Aug;68(8):657-60. doi: 10.1136/jclinpath-2015-202969. Epub 2015 Apr 29.

PMID:
25926041
6.

Loss of the nuclear receptor corepressor SLIRP compromises male fertility.

Colley SM, Wintle L, Searles R, Russell V, Firman RC, Smith S, Deboer K, Merriner DJ, Genevieve B, Bentel JM, Stuckey BG, Phillips MR, Simmons LW, de Kretser DM, O'Bryan MK, Leedman PJ.

PLoS One. 2013 Aug 15;8(8):e70700. doi: 10.1371/journal.pone.0070700. eCollection 2013.

7.

ETS1 regulates NKX3.1 5' promoter activity and expression in prostate cancer cells.

Preece DM, Harvey JM, Bentel JM, Thomas MA.

Prostate. 2011 Mar 1;71(4):403-14. doi: 10.1002/pros.21254. Epub 2010 Sep 14.

PMID:
20842667
8.

Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.

Thomas MA, Preece DM, Bentel JM.

Biochem J. 2010 Jan 15;425(3):575-83. doi: 10.1042/BJ20091109.

PMID:
19886863
9.

ERK/MAPK regulation of the androgen responsiveness of breast cancer cells.

Azzam DG, Tay JW, Greeve MA, Harvey JM, Bentel JM.

Adv Exp Med Biol. 2008;617:429-35. doi: 10.1007/978-0-387-69080-3_41.

PMID:
18497066
10.

The intracellular and nuclear-targeted delivery of an antiandrogen drug by carrier peptides.

Hodoniczky J, Sims CG, Best WM, Bentel JM, Wilce JA.

Biopolymers. 2008;90(5):595-603. doi: 10.1002/bip.20986.

PMID:
18351583
11.

Characterization of columnar cell lesions of the breast: immunophenotypic analysis of columnar alteration of lobules with prominent apical snouts and secretions.

Dessauvagie BF, Zhao W, Heel-Miller KA, Harvey J, Bentel JM.

Hum Pathol. 2007 Feb;38(2):284-92. Epub 2006 Nov 3.

PMID:
17084437
12.

Transcriptional regulation of the homeobox gene NKX3.1 by all-trans retinoic acid in prostate cancer cells.

Thomas MA, Hodgson MC, Loermans SD, Hooper J, Endersby R, Bentel JM.

J Cell Biochem. 2006 Dec 1;99(5):1409-19.

PMID:
16817226
13.

Differential modulation of cell cycle, apoptosis and PPARgamma2 gene expression by PPARgamma agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells.

Hampel JK, Brownrigg LM, Vignarajah D, Croft KD, Dharmarajan AM, Bentel JM, Puddey IB, Yeap BB.

Prostaglandins Leukot Essent Fatty Acids. 2006 May;74(5):283-93. Epub 2006 May 2.

PMID:
16647253
14.

Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.

Buchanan G, Birrell SN, Peters AA, Bianco-Miotto T, Ramsay K, Cops EJ, Yang M, Harris JM, Simila HA, Moore NL, Bentel JM, Ricciardelli C, Horsfall DJ, Butler LM, Tilley WD.

Cancer Res. 2005 Sep 15;65(18):8487-96.

15.

Inhibition of MCF-7 breast cancer cell proliferation by 5alpha-dihydrotestosterone; a role for p21(Cip1/Waf1).

Greeve MA, Allan RK, Harvey JM, Bentel JM.

J Mol Endocrinol. 2004 Jun;32(3):793-810.

PMID:
15171713
16.

Regulation of caltrin mRNA expression by androgens in the murine prostate.

Mirosevich J, Bentel JM, Dawkins JS.

J Androl. 2001 May-Jun;22(3):449-57.

17.

Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function.

Buchanan G, Yang M, Harris JM, Nahm HS, Han G, Moore N, Bentel JM, Matusik RJ, Horsfall DJ, Marshall VR, Greenberg NM, Tilley WD.

Mol Endocrinol. 2001 Jan;15(1):46-56.

PMID:
11145738
18.

Androgen receptor expression in primary prostate cancers of Lobund-Wistar rats and in tumor-derived cell lines.

Bentel JM, Pickering MA, Pollard M, Clements JA, Tilley WD.

In Vitro Cell Dev Biol Anim. 1999 Nov-Dec;35(10):655-62.

PMID:
10614877
19.

Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.

Bentel JM, Birrell SN, Pickering MA, Holds DJ, Horsfall DJ, Tilley WD.

Mol Cell Endocrinol. 1999 Aug 20;154(1-2):11-20.

PMID:
10509795
21.

Androgen receptor expression of proliferating basal and luminal cells in adult murine ventral prostate.

Mirosevich J, Bentel JM, Zeps N, Redmond SL, D'Antuono MF, Dawkins HJ.

J Endocrinol. 1999 Sep;162(3):341-50.

PMID:
10467225
22.

Immunolocalization of apolipoprotein D, androgen receptor and prostate specific antigen in early stage prostate cancers.

Zhang SX, Bentel JM, Ricciardelli C, Horsfall DJ, Haagensen DE, Marshall VR, Tilley WD.

J Urol. 1998 Feb;159(2):548-54.

PMID:
9649289
23.

Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth.

Zeps N, Bentel JM, Papadimitriou JM, D'Antuono MF, Dawkins HJ.

Differentiation. 1998 Mar;62(5):221-6.

PMID:
9566307
24.
25.

Androgen receptors in prostate cancer.

Bentel JM, Tilley WD.

J Endocrinol. 1996 Oct;151(1):1-11. Review. No abstract available.

PMID:
8943763
26.

Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer.

Hall RE, Aspinall JO, Horsfall DJ, Birrell SN, Bentel JM, Sutherland RL, Tilley WD.

Br J Cancer. 1996 Oct;74(8):1175-80.

27.
28.

Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.

Bentel JM, Lebwohl DE, Cullen KJ, Rubin MS, Rosen N, Mendelsohn J, Miller WH Jr.

J Cell Physiol. 1995 Oct;165(1):212-21.

PMID:
7559803
29.

Differential expression of apolipoprotein-D and prostate specific antigen in benign and malignant prostate tissues.

Aspinall JO, Bentel JM, Horsfall DJ, Haagensen DE, Marshall VR, Tilley WD.

J Urol. 1995 Aug;154(2 Pt 1):622-8.

PMID:
7541868
30.

Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression.

Birrell SN, Roder DM, Horsfall DJ, Bentel JM, Tilley WD.

J Clin Oncol. 1995 Jul;13(7):1572-7.

PMID:
7602345
31.

Androgens induce divergent proliferative responses in human breast cancer cell lines.

Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ, Tilley WD.

J Steroid Biochem Mol Biol. 1995 May;52(5):459-67.

PMID:
7748811
32.

Evidence for a novel mechanism of androgen resistance in the human prostate cancer cell line, PC-3.

Tilley WD, Bentel JM, Aspinall JO, Hall RE, Horsfall DJ.

Steroids. 1995 Jan;60(1):180-6.

PMID:
7792809
33.

9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.

Rubin M, Fenig E, Rosenauer A, Menendez-Botet C, Achkar C, Bentel JM, Yahalom J, Mendelsohn J, Miller WH Jr.

Cancer Res. 1994 Dec 15;54(24):6549-56.

34.

Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.

Achkar CC, Bentel JM, Boylan JF, Scher HI, Gudas LJ, Miller WH Jr.

Drug Metab Dispos. 1994 May-Jun;22(3):451-8.

PMID:
8070324
35.

Enhanced invasiveness and metastatic potential of epithelial cell lines cultured in the presence of dimethyl sulphoxide.

Bentel JM, Rhodes GC, Markus I, Smith GJ.

Int J Cancer. 1990 Aug 15;46(2):251-7.

PMID:
2384274
36.

Enhanced anchorage independent colony formation at increased agar concentrations in malignant mouse epithelial cell lines.

Bentel JM, Smith GJ.

In Vitro Cell Dev Biol. 1990 Feb;26(2):103-4. No abstract available.

PMID:
2312493
37.
38.
39.

A cell culture model of chemically and spontaneously derived mouse lung alveologenic carcinoma.

Smith GJ, Steele JG, Bentel JM, Loo CK.

Cell Biol Toxicol. 1988 Sep;4(3):333-48.

PMID:
2465073
40.

Malignant epithelial cell strains cultured from BALB/c mouse lung adenoma.

Smith GJ, Bentel JM.

Cell Biol Int Rep. 1987 Feb;11(2):111-8.

PMID:
3829131
41.

Onset of neoplastic phenotype in an epithelial cell strain from adult BALB/c mouse lung alveolus.

Smith GJ, Bennett FA, Steele JG, Bentel JM.

J Natl Cancer Inst. 1986 Jan;76(1):73-9.

PMID:
3001399

Supplemental Content

Loading ...
Support Center